Navigation Links
Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease
Date:2/11/2010

an Genetic Therapies (HGT). "Our program is the largest and most comprehensive set of Phase III clinical trials conducted to date for Gaucher disease, and we look forward to presenting the results from the remaining trials at future scientific meetings."

Results from Five-Year Study

Ten of 11 adult patients who completed the Phase I/II study of velaglucerase alfa administered at 60 U/kg every other week, enrolled in a long-term extension study. After month-12, all patients were eligible to receive a step-wise dose reduction from 60 U/kg to 45 U/kg (13 weeks) and then to a 30 U/kg maintenance dose upon the achievement of specific therapeutic goals. All patients met therapeutic goals and their dose was subsequently titrated down to the 30U/kg dose. Seven of 10 patients received home infusions during the extension period. Eight patients (4 male, 4 female) have now received velaglucerase alfa treatment for 60 months.

After 5 years, velaglucerase alfa continued to be generally well tolerated and demonstrated substantial and prolonged increases in hemoglobin concentration and platelet count, and substantial and prolonged decreases in liver and spleen volumes in these patients with Type 1 Gaucher disease.

At 60 months, the mean increase in hemoglobin concentration from baseline was +2.4 g/dL (95% CI: 1.6, 3.2; 21.3% change) and the mean increase in platelet count from baseline was +85.1 x10(9)/L (95% CI: 59.8,110.4; 157% change). At 57 months, mean percent reduction in normalized liver volume from baseline was 39% (95% CI: -49.1%,-28.5%) and mean percent reduction in normalized spleen volume from baseline was 74% (95% CI: -89.3%,-58.6%).

Velaglucerase alfa was found to be generally well tolerated in these 10 patients with no drug-related serious adverse events reported. Treatment-emergent adverse events reported by at least 50% of patients included arthralgia, back pain, pyrexia, upper abdomi
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
2. Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page
3. Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
4. Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
5. Shire Re-Launches FOCUS, an Online, Personalized Patient Support Program for Adults with ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII
6. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
7. Shire Continues to Deliver Excellent Growth From Core Products
8. Shire to Present Important Study Findings on its ADHD Treatments at a Major Psychiatric Meeting on October 29 and 30
9. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
10. Shire Targets Fourth Quarter Filing of BLA for REPLAGAL(R) for Fabry Disease With U.S. FDA
11. Shire and Sandoz Settle all Pending Litigation Concerning ADDERALL XR(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014   Health 2.0 announces Bernard ... visionary physicians Eric Topol , Patrick Soon-Shiong , ... Health 2.0 8th Annual Fall Conference this coming Sept. ... year, Health 2.0 is set to host the very first ... session on Consumer Tech & Wearables: Powering Healthy Lifestyles. ...
(Date:7/29/2014)... --   Glide Pharmaceutical Technologies ... an exclusive worldwide licence to an innovative prostate cancer ... University spin-out company.  Under the terms of ... development and commercial milestone payments, and royalties on future ... for additional exclusive licences to FScan diagnostic technologies, for ...
(Date:7/29/2014)... 29, 2014   , ... investigating the efficacy and safety of MSB0010718C in patients with ... rare and aggressive skin cancer lacking effective treatments   ... Phase I clinical trial for the treatment of solid tumors ... Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
Breaking Medicine Technology:Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 2Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5
... , WASHINGTON, June 8 Trust for America,s Health ... a new public opinion survey today which finds that ... reform priority, and overwhelmingly support increasing funding for prevention ... , , In the poll, conducted by Greenberg ...
... Usability Gaps in Remote Patient Monitoring Market , ... leading innovator in remote patient monitoring (RPM), announced today ... for the remote monitoring of patients, vital signs by ... currently available monitoring technologies, dramatically simplifying the way in ...
Cached Medicine Technology:New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 2New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 3New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 4New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 5VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers 2VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers 3VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers 4
(Date:7/29/2014)... 2014 "Acceptance, Recognition, and Control (A.R.C.) ... his own demons and wants other men to heed the ... left. A month later, he had no job, leaving Raymond ... Raymond approached the government for assistance, the emotional disturbance was ... program. But this approach didn’t get to the root of ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Lean and Lovely, ... choice for women who want to wear a bikini in ... Stan Stevenson, prompting an investigative review. , “Our Lean ... designed for women at all fitness levels. Neither your age ... how unfit your body is at the beginning, you will ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Gout was one ... lifestyles have proven that last statement essentially moot since ... many people still do not have are the resources to ... is it costly to maintain treatment for it, but the ... daily activities to a grinding halt. , Alternative ...
(Date:7/29/2014)... Current Back2Basics long-term drug rehab resident Jon ... during his first six months of sobriety. , This ... one foot, once on the other– which was how he ... year ago and was prescribed drugs that I didn’t take ... from home who’d recently completed the program. The six-month long ...
(Date:7/29/2014)... 29, 2014 The Cottages Investment ... Cottages at MeadowLands Memory Care, to break ground July ... suffering from memory loss and forms of dementia, Wade ... the development of Oconto Fall’s first assisted living facility ... of The Cottages Investment Group, LLC will license the ...
Breaking Medicine News(10 mins):Health News:SBPRA Announces the Release of Its Newest Title, "Acceptance, Recognition, and Control (A.R.C.) Against Depression" 2Health News:Lean and Lovely: Review Examining Neghar Fonooni’s Program Released 2Health News:Gout Natural Remedy Report Review | The Ultimate Secret to Eliminating Gout Naturally – Vinamy.com 2Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:The Cottages Investment Group Announces Third Development Project, The Cottages at MeadowLands Memory Care, Oconto Falls 2Health News:The Cottages Investment Group Announces Third Development Project, The Cottages at MeadowLands Memory Care, Oconto Falls 3Health News:The Cottages Investment Group Announces Third Development Project, The Cottages at MeadowLands Memory Care, Oconto Falls 4
... therapy can help patients with a certain type of ... might have otherwise if the same treatment was given ... trial results. , Walter Curran Jr., M.D., professor ... of Thomas Jefferson University and Jeffersons Kimmel Cancer Center ...
... what footwear works best , , FRIDAY, Nov. 9 (HealthDay News) ... and flexible walking shoes than with other types of ... barefoot, the better for the knees, the study finds. , ... only affects your feet but can affect other joints at ...
... death of a loved one, PITTSBURGH, Nov. 9 ... those grieving the death of a loved one. At ... others are experiencing,feelings of sadness and loneliness. The Highmark ... Families, offers peer support,groups and referral services for those ...
... part of the Company,s,commitment to encourage healthier lifestyle ... for the amendment to the Farm Bill that ... proposed by Senate,Agriculture Committee Chairman Tom Harkin (D-IA) ... Senators Harkin and Murkowski for championing the,bipartisan effort ...
... Diabetes Day is,November 14, 2007 and Lifestyle Center ... the 12-Day Stopping Diabetes Program series in Sedona,Arizona. ... diabetes, this,program focuses on intensive lifestyle change as ... Stuart Seale, medical director for the Stopping Diabetes ...
... 9 out of 10 cases, a burst abdominal aortic artery ... A new study -- the largest yet performed -- now ... or heart disease are also at high risk for an ... should also receive ultrasound screening to help spot and correct ...
Cached Medicine News:Health News:Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives 2Health News:Close to Barefoot Best for Arthritic Knees 2Health News:Close to Barefoot Best for Arthritic Knees 3Health News:Close to Barefoot Best for Arthritic Knees 4Health News:Grieving Children and Families Cope with Grief at the Holidays 2Health News:Grieving Children and Families Cope with Grief at the Holidays 3Health News:Mars US Supports Harkin/Murkowski Amendment to Update Nutrition Standards for Foods Sold in Schools 2Health News:New Sedona Stopping Diabetes Program 2Health News:Screening for abdominal aortic aneurysms in women may save lives 2Health News:Screening for abdominal aortic aneurysms in women may save lives 3
The Urology C-Arm Table features motorized actuation of height, X-Y, lateral roll and Trendelenburg motions of the tabletop, and is fully accessorized for urologic procedures....
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
... imaging system that provides clinically ... improved patient care and efficiency.With ... physicians and technologists are now ... detail and more precise definition ...
Medicine Products: